Twitter applies Misleading label to a tweet quoting from Pfizer's EUA, adds a sharing restriction to it: A Twitter user tweeted: "This is in the FDA's original emergency authorization review for the Pfizer vaccine. Regarding Covid survivors: 'available data are insufficient to determine whether such individuals could benefit from vaccination.' HUH? FDA.gov/media/144416/download." The image attached showed the referenced section from the EUA, which in full said "Only 3% of participants had evidence of prior infection at study enrollment, and additional analyses showed that very few COVID-19 cases occurred in these participants over the course of the entire study (9 in the placebo group and 10 in the BNT 162b2 group, only 1 of which occurred 7 days or more after completion of the vaccination regimen - data not shown). The placebo group attack rate from enrollment to the November 14, 2020, data cut-off date was 1.3% both for participants without evidence of prior infection at enrollment (259 cases in 19,81 participants) and for participants with evidence of prior infection at enrollment (9 cases in 670 participants). While limited, these data do suggest that previously infected individuals can be at risk of COVID-19 (i.e., reinfection). However, available data are insufficient to determine whether such individuals could benefit from vaccination." The user had highlighted the last sentence. Twitter placed a Misleading label on the tweet, advising users to click its link to "Learn why health officials recommend a vaccine for most people." Twitter also prevented the tweet from being replied to, shared or liked.